We use cookies and other tools to enhance your experience on our website and to analyze our web traffic.
For more information about these cookies and the data collected, please refer to our Privacy Policy.

Sleep Heart Health Study

Name Label Folder
ace1
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit One (SHHS1))
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit One (SHHS1))

Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ace2
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit Two (SHHS2))
angiotensin-converting-enzyme inhibitor (ACE) inhibitors without diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
aced1
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit One (SHHS1))
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit One (SHHS1))

Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
aced2
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit Two (SHHS2))
angiotensin-converting-enzyme inhibitor (ACE) inhibitors with diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking angiotensin-converting-enzyme inhibitor (ACE) INHIBITORS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar1a1
Anti-Arrhythmics, Class 1A (Sleep Heart Health Study Visit One (SHHS1))
Anti-Arrhythmics, Class 1A (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANTI-ARRHYTHMICS, CLASS 1A within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar1b1
Anti-Arrhythmics, Class 1B (Sleep Heart Health Study Visit One (SHHS1))
Anti-Arrhythmics, Class 1B (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANTI-ARRHYTHMICS, CLASS 1B within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar1c1
Anti-Arrhythmics, Class 1C (Sleep Heart Health Study Visit One (SHHS1))
Anti-Arrhythmics, Class 1C (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANTI-ARRHYTHMICS, CLASS 1C within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar31
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1))
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANTI-ARRHYTHMICS, CLASS 3 within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
benzod1
Benzodiazepines (Sleep Heart Health Study Visit One (SHHS1))
Benzodiazepines (Sleep Heart Health Study Visit One (SHHS1))

Participant taking BENZODIAZEPINES within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
benzod2
Benzodiazepines (Sleep Heart Health Study Visit Two (SHHS2))
Benzodiazepines (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BENZODIAZEPINES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
beta1
Beta-blockers without diuretics (Sleep Heart Health Study Visit One (SHHS1))
Beta-blockers without diuretics (Sleep Heart Health Study Visit One (SHHS1))

Participant taking BETA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
beta2
Beta-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Beta-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BETA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
betad1
Beta-blockers with diuretics (Sleep Heart Health Study Visit One (SHHS1))
Beta-blockers with diuretics (Sleep Heart Health Study Visit One (SHHS1))

Participant taking BETA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
betad2
Beta-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Beta-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BETA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ccb1
Any calcium-channel blocker = CCIR or CCBSR or CCBT (Sleep Heart Health Study Visit One (SHHS1))
Any calcium-channel blocker = CCIR or CCBSR or CCBT (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
diur2
Any Diuretic (Sleep Heart Health Study Visit Two (SHHS2))
Any Diuretic (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANY DIURETIC within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
diuret1
Any diuretic (Sleep Heart Health Study Visit One (SHHS1))
Any diuretic (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANY DIURETIC within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
htnmed1
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit One (SHHS1))
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANY ANTI-HYPERTENSIVE MEDICATION within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
htnmed2
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit Two (SHHS2))
Any Anti-Hypertensive Medication (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANY ANTI-HYPERTENSIVE MEDICATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
insuln1
Insulins (Sleep Heart Health Study Visit One (SHHS1))
Insulins (Sleep Heart Health Study Visit One (SHHS1))

Participant taking INSULINS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
insuln2
Insulins (Sleep Heart Health Study Visit Two (SHHS2))
Insulins (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking INSULINS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
istrd1
Inhaled steroids for asthma (Sleep Heart Health Study Visit One (SHHS1))
Inhaled steroids for asthma (Sleep Heart Health Study Visit One (SHHS1))

Participant taking INHALED STEROIDS FOR ASTHMA within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
istrd2
Inhaled Steroids For Asthma (Sleep Heart Health Study Visit Two (SHHS2))
Inhaled Steroids For Asthma (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking INHALED STEROIDS FOR ASTHMA within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
lipid1
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit One (SHHS1))
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ANY LIPID-LOWERING MEDICATION within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
lipid2
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit Two (SHHS2))
Any Lipid-Lowering Medication (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANY LIPID-LOWERING MEDICATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
mlpd2
Miscellaneous Lipid-Lowering Drugs (Sleep Heart Health Study Visit Two (SHHS2))
Miscellaneous Lipid-Lowering Drugs (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking MISCELLANEOUS LIPID-LOWERING DRUGS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
nsaid1
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (Sleep Heart Health Study Visit One (SHHS1))
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (Sleep Heart Health Study Visit One (SHHS1))

Participant taking NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ntca1
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1))
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit One (SHHS1))

Participant taking NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN monoamine oxidase inhibitor (MAOI) within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ntg1
Nitrates (Sleep Heart Health Study Visit One (SHHS1))
Nitrates (Sleep Heart Health Study Visit One (SHHS1))

Participant taking NITRATES within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
oaia2
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2))
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ORAL ANTI-INFLAMMATORY ASTHMA DRUGS (LEUKOTRIENE RECEPTOR ANTAGONISTS AND INHIBITORS OF LIPO-OXYGENASE) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ohga1
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit One (SHHS1))
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ORAL HYPOGLYCEMIC AGENTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ohga2
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit Two (SHHS2))
Oral Hypoglycemic Agents (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ORAL HYPOGLYCEMIC AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ostrd1
Oral steroids (Sleep Heart Health Study Visit One (SHHS1))
Oral steroids (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ORAL STEROIDS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ostrd2
Oral Steroids (Sleep Heart Health Study Visit Two (SHHS2))
Oral Steroids (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ORAL STEROIDS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
tca1
Tricylic Anti-Depressants (Sleep Heart Health Study Visit One (SHHS1))
Tricylic Anti-Depressants (Sleep Heart Health Study Visit One (SHHS1))

Participant taking TRICYLIC ANTI-DEPRESSANTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
tca2
Tricylic Anti-Depressants (Sleep Heart Health Study Visit Two (SHHS2))
Tricylic Anti-Depressants (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking TRICYLIC ANTI-DEPRESSANTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
a2a2
Angiotensin Type 2 Antagonists (Sleep Heart Health Study Visit Two (SHHS2))
Angiotensin Type 2 Antagonists (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANGIOTENSIN TYPE 2 ANTAGONISTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
a2ad2
Combinations Of Angiotensin II Antagonists Plus Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Combinations Of Angiotensin II Antagonists Plus Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking COMBINATIONS OF ANGIOTENSIN II ANTAGONISTS PLUS DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
adpi2
Inhibitors Of Adenosine Diphosphate (ADP)-Induced Platelet Aggregation (Sleep Heart Health Study Visit Two (SHHS2))
Inhibitors Of Adenosine Diphosphate (ADP)-Induced Platelet Aggregation (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking INHIBITORS OF Adenosine Diphosphate (ADP)-INDUCED PLATELET AGGREGATION within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
agdi2
Alpha-Glucosidase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2))
Alpha-Glucosidase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ALPHA-GLUCOSIDASE INHIBITORS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
alpha1
Alpha-Blockers Without Diuretics (Sleep Heart Health Study Visit One (SHHS1))
Alpha-Blockers Without Diuretics (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ALPHA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
alpha2
Alpha-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Alpha-Blockers Without Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ALPHA-BLOCKERS WITHOUT DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
alphad1
Alpha-Blockers With Diuretics (Sleep Heart Health Study Visit One (SHHS1))
Alpha-Blockers With Diuretics (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ALPHA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
alphad2
Alpha-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Alpha-Blockers With Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ALPHA-BLOCKERS WITH DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
alzh2
Acetylcholine Esterase Inhibitors For Alzheimers (Sleep Heart Health Study Visit Two (SHHS2))
Acetylcholine Esterase Inhibitors For Alzheimers (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ACETYLCHOLINE ESTERASE INHIBITORS FOR ALZHEIMERS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
amlod2
Amlodipine (Sleep Heart Health Study Visit Two (SHHS2))
Amlodipine (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking AMLODIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar1a2
Anti-Arrhythmics, Class 1A (Sleep Heart Health Study Visit Two (SHHS2))
Anti-Arrhythmics, Class 1A (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANTI-ARRHYTHMICS, CLASS 1A within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar1b2
Anti-Arrhythmics, Class 1B (Sleep Heart Health Study Visit Two (SHHS2))
Anti-Arrhythmics, Class 1B (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANTI-ARRHYTHMICS, CLASS 1B within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar1c2
Anti-Arrhythmics, Class 1C (Sleep Heart Health Study Visit Two (SHHS2))
Anti-Arrhythmics, Class 1C (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANTI-ARRHYTHMICS, CLASS 1C within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
anar32
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit Two (SHHS2))
Anti-Arrhythmics, Class 3 (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANTI-ARRHYTHMICS, CLASS 3 within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
asa1
Aspirin From 280804 (Anti-Inflam Agents) (Sleep Heart Health Study Visit One (SHHS1))
Aspirin From 280804 (Anti-Inflam Agents) (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
asa2
Aspirin From 280804 (Anti-Inflam Agents) (Sleep Heart Health Study Visit Two (SHHS2))
Aspirin From 280804 (Anti-Inflam Agents) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
basq1
Bile-acid sequestrant (Sleep Heart Health Study Visit One (SHHS1))
Bile-acid sequestrant (Sleep Heart Health Study Visit One (SHHS1))

Participant taking BILE-ACID SEQUESTRANTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
basq2
Bile-Acid Sequestrants (Sleep Heart Health Study Visit Two (SHHS2))
Bile-Acid Sequestrants (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BILE-ACID SEQUESTRANTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
bgnd2
Biguanides (Sleep Heart Health Study Visit Two (SHHS2))
Biguanides (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking BIGUANIDES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ccb2
Any Calcium-Channel Blocker (Ccir Or Ccbsr Or Ccbt) (Sleep Heart Health Study Visit Two (SHHS2))
Any Calcium-Channel Blocker (Ccir Or Ccbsr Or Ccbt) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANY CALCIUM-CHANNEL BLOCKER = CCIR OR CCBSR OR CCBT within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ccbir1
Immediate-release CCBS = NFIR or DIHIR or VERIR or DLTIR (Sleep Heart Health Study Visit One (SHHS1))
Immediate-release CCBS = NFIR or DIHIR or VERIR or DLTIR (Sleep Heart Health Study Visit One (SHHS1))

Participant taking IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ccbir2
Immediate-Release Ccbs (Nifir Or Dihir Or Verir Or Dltir) (Sleep Heart Health Study Visit Two (SHHS2))
Immediate-Release Ccbs (Nifir Or Dihir Or Verir Or Dltir) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking IMMEDIATE-RELEASE CCBS = NIFIR OR DIHIR OR VERIR OR DLTIR within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ccbsr1
Slow-release CCBS = NIFSR or DIHSR or VERSR or DLTSR or AMLOD (Sleep Heart Health Study Visit One (SHHS1))
Slow-release CCBS = NIFSR or DIHSR or VERSR or DLTSR or AMLOD (Sleep Heart Health Study Visit One (SHHS1))

Participant taking SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ccbsr2
Slow-Release Ccbs (Nifsr Or Dihsr Or Versr Or Dltsr Or Amlod) (Sleep Heart Health Study Visit Two (SHHS2))
Slow-Release Ccbs (Nifsr Or Dihsr Or Versr Or Dltsr Or Amlod) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking SLOW-RELEASE CCBS = NIFSR OR DIHSR OR VERSR OR DLTSR OR AMLOD within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ccbt2
T-Type Calcium-Channel Blocker (Sleep Heart Health Study Visit Two (SHHS2))
T-Type Calcium-Channel Blocker (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking T-TYPE CALCIUM-CHANNEL BLOCKER within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
cox22
Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2))
Cox-2 Inhibitors (nonsteroidal anti-inflammatory drug (NSAID) Agents) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking COX-2 INHIBITORS (nonsteroidal anti-inflammatory drug (NSAID) AGENTS); SEPARATE FROM nonsteroidal anti-inflammatory drug (NSAID) VARIABLE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
dig1
Digitalis preparations (Sleep Heart Health Study Visit One (SHHS1))
Digitalis preparations (Sleep Heart Health Study Visit One (SHHS1))

Participant taking DIGITALIS PREPARATIONS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
dig2
Digitalis Preparations (Sleep Heart Health Study Visit Two (SHHS2))
Digitalis Preparations (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking DIGITALIS PREPARATIONS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
dihir2
Immediate-Release Dihydropyridines Other Than Nifedipine (Sleep Heart Health Study Visit Two (SHHS2))
Immediate-Release Dihydropyridines Other Than Nifedipine (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking IMMEDIATE-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
dihsr2
Slow-Release Dihydropyridines Other Than Nifedipine Or Amlopidine (Sleep Heart Health Study Visit Two (SHHS2))
Slow-Release Dihydropyridines Other Than Nifedipine Or Amlopidine (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking SLOW-RELEASE DIHYDROPYRIDINES OTHER THAN NIFEDIPINE OR AMLOPIDINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
dltir2
Immediate-Release Diltiazem (Sleep Heart Health Study Visit Two (SHHS2))
Immediate-Release Diltiazem (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking IMMEDIATE-RELEASE DILTIAZEM within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
dltsr2
Slow-Release Diltiazem (Sleep Heart Health Study Visit Two (SHHS2))
Slow-Release Diltiazem (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking SLOW-RELEASE DILTIAZEM within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
edd2
Erectile Dysfunction Drugs (Sleep Heart Health Study Visit Two (SHHS2))
Erectile Dysfunction Drugs (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ERECTILE DYSFUNCTION DRUGS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
estrgn1
Estrogens, Excluding Vaginal Creams (Sleep Heart Health Study Visit One (SHHS1))
Estrogens, Excluding Vaginal Creams (Sleep Heart Health Study Visit One (SHHS1))

Participant taking ESTROGENS, EXCLUDING VAGINAL CREAMS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
estrgn2
Estrogens, Excluding Vaginal Creams (Sleep Heart Health Study Visit Two (SHHS2))
Estrogens, Excluding Vaginal Creams (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ESTROGENS, EXCLUDING VAGINAL CREAMS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
fibr2
Fibrates (Sleep Heart Health Study Visit Two (SHHS2))
Fibrates (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking FIBRATES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
h2b2
H-2 Blockers (Sleep Heart Health Study Visit Two (SHHS2))
H-2 Blockers (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking H-2 BLOCKERS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
hctz1
Thiazide diuretics without k-sparing agents (Sleep Heart Health Study Visit One (SHHS1))
Thiazide diuretics without k-sparing agents (Sleep Heart Health Study Visit One (SHHS1))

Participant taking THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
hctz2
Thiazide Diuretics Without K-Sparing Agents (Sleep Heart Health Study Visit Two (SHHS2))
Thiazide Diuretics Without K-Sparing Agents (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking THIAZIDE DIURETICS WITHOUT K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
hctzk1
Thiazide diuretics with k-sparing agents (Sleep Heart Health Study Visit One (SHHS1))
Thiazide diuretics with k-sparing agents (Sleep Heart Health Study Visit One (SHHS1))

Participant taking THIAZIDE DIURETICS WITH K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
hctzk2
Thiazide Diuretics With K-Sparing Agents (Sleep Heart Health Study Visit Two (SHHS2))
Thiazide Diuretics With K-Sparing Agents (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking THIAZIDE DIURETICS WITH K-SPARING AGENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
hprns2
Heparins (Sleep Heart Health Study Visit Two (SHHS2))
Heparins (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking HEPARINS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
iprtr2
Anticholinergics + Combination With Beta2-Agonist (Sleep Heart Health Study Visit Two (SHHS2))
Anticholinergics + Combination With Beta2-Agonist (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking ANTICHOLINERGICS + COMBINATION WITH BETA2-AGONIST within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
kblkr2
K-Channel Blockers To Enhance Insulin Secretion For Diabetics (Sleep Heart Health Study Visit Two (SHHS2))
K-Channel Blockers To Enhance Insulin Secretion For Diabetics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking K-CHANNEL BLOCKERS TO ENHANCE INSULIN SECRETION FOR DIABETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
kcl2
Potassium Supplements (Sleep Heart Health Study Visit Two (SHHS2))
Potassium Supplements (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking POTASSIUM SUPPLEMENTS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
kspr2
Potassium-Sparing Agents Alone (Sleep Heart Health Study Visit Two (SHHS2))
Potassium-Sparing Agents Alone (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking POTASSIUM-SPARING AGENTS ALONE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
loop1
Loop diuretics (Sleep Heart Health Study Visit One (SHHS1))
Loop diuretics (Sleep Heart Health Study Visit One (SHHS1))

Participant taking LOOP DIURETICS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
loop2
Loop Diuretics (Sleep Heart Health Study Visit Two (SHHS2))
Loop Diuretics (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking LOOP DIURETICS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
niac1
Niacin and nicotinic acid (Sleep Heart Health Study Visit One (SHHS1))
Niacin and nicotinic acid (Sleep Heart Health Study Visit One (SHHS1))

Participant taking NIACIN AND NICOTINIC ACID within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
niac2
Niacin And Nicotinic Acid (Sleep Heart Health Study Visit Two (SHHS2))
Niacin And Nicotinic Acid (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking NIACIN AND NICOTINIC ACID within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
nifir2
Immediate-Release Nifedipine (Sleep Heart Health Study Visit Two (SHHS2))
Immediate-Release Nifedipine (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking IMMEDIATE-RELEASE NIFEDIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
nifsr2
Slow-Release Nifedipine (Sleep Heart Health Study Visit Two (SHHS2))
Slow-Release Nifedipine (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking SLOW-RELEASE NIFEDIPINE within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
nsaid2
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (Sleep Heart Health Study Visit Two (SHHS2))
Non-Steroidal Anti-Inflammatory Agents, Excluding Aspirin (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking NON-STEROIDAL ANTI-INFLAMMATORY AGENTS, EXCLUDING ASPIRIN within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ntca2
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit Two (SHHS2))
Non-Tricyclic Antidepressants Other Than monoamine oxidase inhibitor (MAOI) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking NON-TRICYCLIC ANTIDEPRESSANTS OTHER THAN monoamine oxidase inhibitor (MAOI) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ntg2
Nitrates (Sleep Heart Health Study Visit Two (SHHS2))
Nitrates (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking NITRATES within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
otch2b2
Over-The-Counter H-2 Blockers (Sleep Heart Health Study Visit Two (SHHS2))
Over-The-Counter H-2 Blockers (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking OVER-THE-COUNTER H-2 BLOCKERS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
pdei1
Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit One (SHHS1))
Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit One (SHHS1))

Participant taking PHOSPHODIESTERASE INHIBITORS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
pdei2
Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2))
Phosphodiesterase Inhibitors (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking PHOSPHODIESTERASE INHIBITORS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
ppi2
Proton Pump Inhibitors (Sleep Heart Health Study Visit Two (SHHS2))
Proton Pump Inhibitors (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking PROTON PUMP INHIBITORS within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
premar1
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit One (SHHS1))
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit One (SHHS1))

Participant taking PREMARIN (CONJUGATED ESTROGENS) within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
premar2
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit Two (SHHS2))
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking PREMARIN (CONJUGATED ESTROGENS) within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
prknsn2
Drugs Used To Treat Parkinson's (Sleep Heart Health Study Visit Two (SHHS2))
Drugs Used To Treat Parkinson's (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking DRUGS USED TO TREAT PARKINSON'S within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
prob2
Probucol (Sleep Heart Health Study Visit Two (SHHS2))
Probucol (Sleep Heart Health Study Visit Two (SHHS2))

Participant taking PROBUCOL within two weeks of the Sleep Heart Health Study Visit Two (SHHS2) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications
progst1
Progestins (Sleep Heart Health Study Visit One (SHHS1))
Progestins (Sleep Heart Health Study Visit One (SHHS1))

Participant taking PROGESTINS within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Medications